0001410384-20-000037.txt : 20200303 0001410384-20-000037.hdr.sgml : 20200303 20200303183101 ACCESSION NUMBER: 0001410384-20-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200228 FILED AS OF DATE: 20200303 DATE AS OF CHANGE: 20200303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flake Matthew P CENTRAL INDEX KEY: 0001597592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36350 FILM NUMBER: 20684649 MAIL ADDRESS: STREET 1: 13785 RESEARCH BLVD. STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78750 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Q2 Holdings, Inc. CENTRAL INDEX KEY: 0001410384 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 202706637 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 BUSINESS PHONE: 512-275-0072 MAIL ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 150 CITY: Austin STATE: TX ZIP: 78750 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings, Inc. DATE OF NAME CHANGE: 20120103 FORMER COMPANY: FORMER CONFORMED NAME: CBG Holdings Inc DATE OF NAME CHANGE: 20070821 4 1 wf-form4_158327824446103.xml FORM 4 X0306 4 2020-02-28 0 0001410384 Q2 Holdings, Inc. QTWO 0001597592 Flake Matthew P 13785 RESEARCH BLVD. SUITE 150 AUSTIN TX 78750 1 1 0 0 President and CEO Common Stock 2020-02-28 4 M 0 25000 8.35 A 277439 D Common Stock 2020-02-28 4 S 0 25000 73.98 D 252439 D Stock Option (right to buy) 8.35 2020-02-28 4 M 0 25000 0 D 2016-01-24 2021-01-24 Common Stock 25000.0 23664 D Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.65 to $75.00 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option grant vested as to 1/2 of the total option grant on January 24, 2016, and thereafter as to 1/32 of the total option grant monthly. The option grant becomes exercisable as it vests. M. Scott Kerr, as attorney-in-fact 2020-03-03